As of 2025-09-18, the Intrinsic Value of Atea Pharmaceuticals Inc (AVIR) is -42.88 USD. This Atea valuation is based on the model Peter Lynch Fair Value. With the current market price of 2.91 USD, the upside of Atea Pharmaceuticals Inc is -1,573.63%.
Based on its market price of 2.91 USD and our intrinsic valuation, Atea Pharmaceuticals Inc (AVIR) is overvalued by 1,573.63%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -42.88 - -42.88 | -42.88 | -1,573.63% |
| P/E | (32.59) - (34.44) | (33.79) | -1261.2% |
| DDM - Stable | (11.58) - (38.58) | (25.08) | -961.7% |
| DDM - Multi | (12.57) - (33.87) | (18.49) | -735.3% |
| Market Cap (mil) | 230.94 |
| Beta | 0.67 |
| Outstanding shares (mil) | 79.36 |
| Enterprise Value (mil) | 143.22 |
| Market risk premium | 4.60% |
| Cost of Equity | 11.19% |
| Cost of Debt | 5.00% |
| WACC | 8.06% |